NCT00432510

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

Protocol LEVP2006-5: Pharmacokinetics of C1INH-nf in Hereditary Angioedema Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 27 (actual)
• Sponsor: Shire · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study objective was to describe the pharmacokinetics (PK) of one or two doses of C1 esterase inhibitor (C1INH-nf) in hereditary angioedema (HAE) subjects who were not experiencing an HAE attack.

Conditions

• Hereditary Angioedema

Interventions

Type	Name	Description
DRUG	C1 esterase inhibitor [human] (C1INH-nf)

Timeline

• Start date: 2006-10-09
• Primary completion: 2007-02-28
• Completion: 2007-02-28
• First posted: 2007-02-08
• Last updated: 2021-06-03

Locations

6 sites across 1 country: United States